Company · CIK 0002114044 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Hemab Therapeutics Holdings, Inc. · COAG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 PForm 4 → | Jun 17, 6:24 pm EDT | RA CAPITAL MANAGEMENT, L.P. +310% Owner | 67,669 | $24.97 | $1,689,818 | 6,444,637 | +1.06% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 AForm 4 → | Sep 25, 4:45 pm EDT | Keli WalbertDirector | 36,000 | — | — | 36,000 | — |